HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmavite, GNC Launching SAM-e Dietary Supplement For Joints/Mood

This article was originally published in The Tan Sheet

Executive Summary

Pharmavite and General Nutrition are introducing dietary supplements containing S-adenosylmethionine, a naturally occurring compound said to improve mood and help joints stay supple. BASF supplies the compound to Pharmavite and GNC; the raw material is produced in Italy.

You may also be interested in...



Bonafide Women’s Health Acquires SAM-e Formulation With High Bioavailability

Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.

Nature Made Vinpocetine Promoted For Enhanced Mental Acuity

Pharmavite's Nature Made line of nutritional supplements is expanding to include the first mass market product in the U.S. that contains vinpocetine as a stand-alone ingredient. A derivative of the periwinkle plant, the botanical is promoted as helping "improve memory and concentration."

Viactiv Single Product Introduction Led To Future Line Success - Leiner Exec

Dietary supplement companies should focus on launching single branded products instead of whole lines in order to best attract and establish consumer interest, Leiner Health Products New Products Marketing Director David Weinberg advised at the Nutrimarket conference in San Francisco March 27-28.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139975

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel